143 related articles for article (PubMed ID: 24258357)
1. Increased expression of stomatin-like protein 2 (STOML2) predicts decreased survival in gastric adenocarcinoma: a retrospective study.
Li XH; He F; Yan SM; Li Y; Cao Y; Huang CY; Zhou ZW
Med Oncol; 2014 Jan; 31(1):763. PubMed ID: 24258357
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma.
Yan S; He F; Luo R; Wu H; Huang M; Huang C; Li Y; Zhou Z
Tumour Biol; 2016 May; 37(5):6125-33. PubMed ID: 26611647
[TBL] [Abstract][Full Text] [Related]
3. An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.
Han CL; Chen JS; Chan EC; Wu CP; Yu KH; Chen KT; Tsou CC; Tsai CF; Chien CW; Kuo YB; Lin PY; Yu JS; Hsueh C; Chen MC; Chan CC; Chang YS; Chen YJ
Mol Cell Proteomics; 2011 Apr; 10(4):M110.003087. PubMed ID: 21209152
[TBL] [Abstract][Full Text] [Related]
4. Stomatin-like protein 2 expression is associated with clinical survival in patients with cervical cancer.
Xiao B; Xie Z; Guo L; Wu J; Zhang H
Int J Clin Exp Pathol; 2015; 8(2):1804-9. PubMed ID: 25973071
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-κB/MMP-9 pathway.
Song L; Liu L; Wu Z; Lin C; Dai T; Yu C; Wang X; Wu J; Li M; Li J
J Pathol; 2012 Feb; 226(3):534-43. PubMed ID: 21960069
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of transcription elongation factor A-like 7 is associated with gastric adenocarcinoma prognosis.
Huang CY; Chen YM; Zhao JJ; Chen YB; Jiang SS; Yan SM; Zhao BW; Pan K; Wang DD; Lv L; Li YF; Wang W; Zhou ZW; Xia JC
PLoS One; 2013; 8(1):e54671. PubMed ID: 23372750
[TBL] [Abstract][Full Text] [Related]
7. Silence of Stomatin-Like Protein 2 Represses Migration and Invasion Ability of Human Liver Cancer Cells via Inhibiting the Nuclear Factor Kappa B (NF-κB) Pathway.
Zhu W; Li W; Geng Q; Wang X; Sun W; Jiang H; Pu X
Med Sci Monit; 2018 Oct; 24():7625-7632. PubMed ID: 30359340
[TBL] [Abstract][Full Text] [Related]
8. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
[TBL] [Abstract][Full Text] [Related]
9. Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma.
Wang J; Shen H; Fu G; Zhao D; Wang W
Oncotarget; 2017 Feb; 8(6):9442-9450. PubMed ID: 28038462
[TBL] [Abstract][Full Text] [Related]
10. A novel member of the STOMATIN/EPB72/mec-2 family, stomatin-like 2 (STOML2), is ubiquitously expressed and localizes to HSA chromosome 9p13.1.
Owczarek CM; Treutlein HR; Portbury KJ; Gulluyan LM; Kola I; Hertzog PJ
Cytogenet Cell Genet; 2001; 92(3-4):196-203. PubMed ID: 11435687
[TBL] [Abstract][Full Text] [Related]
11. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer.
Fu X; Xie W; Song X; Wu K; Xiao L; Liu Y; Zhang L
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):687-692. PubMed ID: 28274596
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer.
Liu D; Zhang L; Shen Z; Tan F; Hu Y; Yu J; Li G
Gastric Cancer; 2013 Oct; 16(4):498-504. PubMed ID: 23371255
[TBL] [Abstract][Full Text] [Related]
14. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
[TBL] [Abstract][Full Text] [Related]
15. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
Hu X; Huang Z; Liao Z; He C; Fang X
Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
17. Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma.
Xu CC; Yue L; Wei HJ; Zhao WW; Sui AH; Wang XM; Qiu WS
Pathol Res Pract; 2013 Aug; 209(8):479-85. PubMed ID: 23822993
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
20. Coexisting overexpression of STOML1 and STOML2 proteins may be associated with pathology of oral squamous cell carcinoma.
Wang D; Qi H; Li A; Deng F; Xu Y; Hu Z; Liu Q; Wang Y
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Jun; 129(6):591-599.e3. PubMed ID: 32402568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
